CEO SUMMARY: Various technologies that automate cytology and Pap smear screening entered the clinical marketplace during the last four years. Because managed healthcare views new technology with a more skeptical eye than fee-for-service healthcare, THE DARK REPORT has provided extensive analysis for our clients on how and why the market has embraced or rejected this …
Wedding Between AutoCyte and NeoPath Will Spawn A Single Prep/Screen System Read More »
